Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
This study is currently recruiting participants.
Study NCT00774020   Information provided by Novartis
First Received: October 15, 2008   Last Updated: November 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Paget's Disease of Bone
Additional conditions recognized in this trial
Bone Diseases
Osteitis Deformans
More general conditions related to this trial
Musculoskeletal Diseases
Interventions listed in this trial
Zoledronic acid
Additional drug interventions recognized in this trial
Diphosphonates
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services